Grace Therapeutics (GRCE) Total Non-Current Liabilities (2013 - 2026)
Grace Therapeutics (GRCE) posted Total Non-Current Liabilities of $2.76 million for fiscal Q4 2026 (quarter ended Mar 31, 2026), down 35.0% from $4.24 million a year earlier and down 23.3% from the prior quarter.
Grace Therapeutics (GRCE) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends
Since fiscal Q4 2013, Grace Therapeutics has reported Total Non-Current Liabilities for 45 quarters.
- Annual Total Non-Current Liabilities has declined for four consecutive fiscal years, though with a five-year compound annual growth rate of 11.8% (FY2021 to FY2026).
- In prior fiscal years, Grace Therapeutics' Total Non-Current Liabilities was $4.24 million in FY2025 (-41.1%), $7.2 million in FY2024 (-35.5%), $11.17 million in FY2023 (-45.1%) and $20.34 million in FY2022.
- The fiscal Q4 2026 figure stands as the lowest quarterly Total Non-Current Liabilities since fiscal Q1 2022.
- On a year-over-year basis, Total Non-Current Liabilities has declined in each of the last seven quarters, with an average decline of 34.9% over the last seven quarters.
- The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was fiscal Q3 2023, with growth of 593.2%; the weakest was fiscal Q2 2024, with a decline of 61.4%.
- According to Business Quant data, Total Non-Current Liabilities for the three prior fiscal quarters was $3.6 million (Q3 2026), $3.56 million (Q2 2026) and $4.63 million (Q1 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 60.81 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 102.65 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 117.60 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 79.95 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | -36.84 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 76.12 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 36.05 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 96.04 Bn |
| 10 | Grace Therapeutics | 35.10 Mn | -35.61 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 2.76 Mn |
| Dec 31, 2025 | 3.60 Mn |
| Sep 30, 2025 | 3.56 Mn |
| Jun 30, 2025 | 4.63 Mn |
| Mar 31, 2025 | 4.24 Mn |
| Dec 31, 2024 | 5.30 Mn |
| Sep 30, 2024 | 6.61 Mn |
| Jun 30, 2024 | 7.39 Mn |
| Mar 31, 2024 | 7.20 Mn |
| Dec 31, 2023 | 8.17 Mn |
| Sep 30, 2023 | 8.01 Mn |
| Mar 31, 2023 | 11.17 Mn |
| Dec 31, 2022 | 20.08 Mn |
| Sep 30, 2022 | 20.75 Mn |
| Mar 31, 2022 | 20.34 Mn |
| Dec 31, 2021 | 2.90 Mn |
| Sep 30, 2021 | 4.48 Mn |
| Jun 30, 2021 | 2.35 Mn |
| Mar 31, 2021 | 1.58 Mn |
| Dec 31, 2020 | 2.25 Mn |
Grace Therapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=GRCE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();